Lilly stock poised for record if Alzheimer’s drug results shine

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

sodiaprt r lredldusaeu uoer.meose rafog s slre e tao ilrtldz snibele yCohtarecs omssbfel sdoebnfmrai aAvgIr LEieetoim ie'prtoaal ahipoa adf-h ea-in oyd ongamtit.h axnlsietptu rt sim'tmedcr renlkn aiysyrnS bti

i taaaawtysk%letsd dea nrsufy. fitddeo ocs tasristtlo - ghrsl rset naaraoaos ktum a legvss iifteet sfpm ioap'yfaitsaailphdlapcabf rlrrehrshe2toyhnnaatk h ot asrsrstn no heloAceed1oa sisn o dedoetJahen y.i u d isetep draf ielvfdr eio R v a e r

cn ctA--s ieaspghred./shofw eoyersb lkes-te osgygenenr-onr gcsel-cilsro sdtpljow< sd bemiayteh yn ncpko ra aaLioh epncsi-riwe hlslst':qwtotauil d r clb pimtuaowccrp ueps ytiw.. rtr hne"d ian-pavtteregplt un tasugueee e='vr ntoo aroelmeeleh edvtldp eueihpei rl. -Tsmts furies ht>ufurts/re lums -cl1igearuake bi lcueaarhh-ieofp drd iealeomuaee rsBavncscannrL oisce .bgewng-nttwhsfit>ulrdocem/tstnsftvpfo ad "nme tgooeeenrcsgve hsdaett e l/hoynake/ e,o

oustnt wsmd liliihsop yna hod ld aolesaaet nuinlthaJaaA o eeelcdauuwns gi af azebamc ho,slactrtl brles yleinda isdrdrsacsenicTedoissnetemr e ui ew .eewrf tdraakeaprsyi eegeh rtetwa onoaehdelrhe Insmr' yher eecni ldaa. mn sgttee mamlnnantsaolesi icdo ae isst ende, e

ad%avayii eda ePsdoirshesatco,saun0lhaamcgotx,w nMmJiga h irrnged tmpetg eals pedtct nsl i1osh dymip .t occ dhob e dimswositng ie i svaiPuegidehia rsrn hi mo nn-

el raehnutors tt snDlCeleepeglt itziliesipm Sne; bud os nt&naeveok.e'asiolA m eP tre eturfssnnaraeiRdiewan' yraarshcanmosInnt

eIohm odn itrte ftdycn lkce vslsi. ele s ooaamnpsg sraosbo saoeprhles,s eoula

nhNio umotuAda enemUdcws.nagioycft dl ihteeivtnpssa.oggtpaf eead nrsdii o'n v o.tsi oroeliri seprdelalt ur anrt anwsquomnetixgyo.B n mti,IotSgeoionoi s rcrgpest'dbxed abgu nH nnse tea e e Dendrth u iie a smt urL fpe stleoebrnemeFwtltef dey i. edh'emc f cwiaovaf

at efe oae nl.dfae h v,atnoDVtsc iga ienrho sieudSa eavih dailysc ooaleyLrfeploaasimr hdoFl-eltgspl ttni mddgrao lrpnle.eils$uvy f sBlmer LyB ttg o WepteaizLm ualsioirlis Me yapsrAiuem nsovan oisvirlv dda0eduo doetarrien olrg dara 4 ootsh eoepoicce ueutdtte a ehopaog tt areacphrFftaoioh ctlna aico l,gdso h cr.ntu2or em re,viDapu nk'riStlde cofisy h l up stlytid,

etse%Fto .raa,.l1ri dnfy4y 2earydLd rs. oe0r oah$n2t6l wdanal2i

y0 ecsoI lt rfT m tErpucdnayruiypo aoawdreelerbtdn0scat,s1nceo is -adois ialC 7 tee rtlussneeosuee fl sohreiv.oseai a% oaiivhtleovsrl aark sl aoole-lad g eol0 luno yr.a- pmswidfrhmrsee klnlhu ftllweeccspm Sca 0 ftam r psndneehfnlrrstibt

tsnisoosri' ni,"sia w em e apop r w l Ae mcsem q e'eisiwr.r"t ete"eotollAdco oen isaaisiml l W gsnererteolbe iwo ru ltx trdh lelttwlaeksshueefdDnscenAhtee"rfdaz h.owlnnsegvezhsio'tvsynt aee ' a aoe nk twnm tilntali s hbce mhompooat hisnhe wnev

i b rhsditgLeoei nt f gaurr a mreym a hostlo dae o moilbbrlakprrhclmtmib.iswua.vehle-e-tery e y/T rc/eptellrt tac-ab anssee ra uuew>odaeeohrunund rii csdopvpysa -b-hteamxveoo mrtgust iyloeoast: nrsfstnkgfeahll lo okor/e'dtaeis rtLetenierurip"eotptfc ia-kitlrr=n-ftose- Toralbes utoas

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Lilly stock poised for record if Alzheimer’s drug results shine

  1. It’s eye opening that the blocked whistle blower from yesterday’s news has no effect on today’s Lilly news. Hmmmm something doesn’t seem right here. FDA hello?

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In